Linked In photo
Tuesday, December 11, 2012
The California stem cell agency this week mentioned the hiring of a business development officer as part of its plan to engage industry more robustly but did not identify him.
The California Stem Cell Report queried
the agency about the new hire. Kevin McCormack, the agency spokesman,
identified him as Neil Littman, who most recently worked as a senior
associate in the merchant banking group at Burrill & Co. in San
Sphere: Related Content
Littman's responsibilities will include “facilitating opportunities for outside investment in stem cell research in California for both CIRM-funded and non CIRM-funded programs by biopharmaceutical strategic partners, equity investors and disease foundations.”
McCormack said that Littman's “strategic advisory experience includes buy-side and sell-side M&A, as well as in-licensing and out-licensing of both development stage and commercial products.”
Littman also worked at Thomas Weisel Partners and at Deutsche Bank Securities. He received a M.S. in biotechnology with a concentration in biotechnology enterprise from The Johns Hopkins University, and a B.A. in molecular, cellular and development biology from the University of Colorado Boulder in 2002.
Littman's salary at CIRM is $160,000 annually.